MEDWAVE INC
SC 13D, 1996-05-30
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: BIOSPECIFICS TECHNOLOGIES CORP, DEF 14A, 1996-05-30
Next: AGRIBIOTECH INC, SC 13D, 1996-05-30




                                                    OMB APPROVAL
                                          -------------------------------
                                          OMB Number            3235-0145
                                          Expires:       October 31, 1994
                                          Estimated average burden
                                          hours per response  . . . 14.90



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C.  20549

                                  SCHEDULE 13D
                    Under the Securities Exchange Act of 1934
                               (Amendment No. __)*

                                  MEDWAVE, INC.
                                (Name of Issuer)

                           Common Stock, no par value
                         (Title of Class of Securities)

                                    585081102    
                                 (CUSIP Number)

                             William D. Corneliuson
       777 East Wisconsin Avenue, Suite 3020, Milwaukee, Wisconsin  53202,
                                  (414) 291-7400
           (Name, Address and Telephone Number of Person Authorized to
                       Receive Notices and Communications)

                                  May 23, 1996                         
             (Date of Event which Requires Filing of this Statement)

   If the filing person has previously filed a statement on Schedule 13G to
   report the acquisition which is the subject of this Schedule 13D, and is
   filing this schedule because of Rule 13d-1(b)(3) or (4), check the
   following box  [_].

   Check the following box if a fee is being paid with the statement  [X]. 
   (A fee is not required only if the reporting person:  (1) has a previous
   statement on file reporting beneficial ownership of more than five percent
   of the class of securities described in Item 1; and (2) has filed no
   amendment subsequent thereto reporting beneficial ownership of five
   percent or less of such class.)  (See Rule 13d-7.)

   Note:     Six copies of this statement, including all exhibits, should be
   filed with the Commission.  See Rule 13d-1(a) for other parties to whom
   copies are to be sent.

   *    The remainder of this cover page shall be filled out for a reporting
   person's initial filing on this form with respect to the subject class of
   securities, and for any subsequent amendment containing information which
   would alter disclosures provided in a prior cover page.

   The information required on the remainder of this cover page shall not be
   deemed to be "filed" for the purpose of Section 18 of the Securities
   Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
   that Section of the Act but shall be subject to all other provisions of
   the Act (however, see the Notes).

   <PAGE>
          CUSIP No. 585081102


     1   NAME OF REPORTING PERSON
         S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

              William D. Corneliuson - ###-##-####

     2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*           (a)  [_]
                                                                     (b)  [_]
              N/A

     3   SEC USE ONLY


     4   SOURCE OF FUNDS*

              PF

     5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
         PURSUANT TO ITEMS 2(d) OR 2(e)                                  [_]



     6   CITIZENSHIP OR PLACE OF ORGANIZATION

              United States

                     7  SOLE VOTING POWER
      NUMBER OF
                             240,000
        SHARES
                     8  SHARED VOTING POWER
     BENEFICIALLY
                             0
       OWNED BY
                     9  SOLE DISPOSITIVE POWER
         EACH
                             240,000
      REPORTING

        PERSON
                    10  SHARED DISPOSITIVE POWER
         WITH
                             0


    11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

              240,000

    12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
         SHARES*                                                          [_]

              N/A


    13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

              5.1%


    14   TYPE OF REPORTING PERSON*

              IN


                      *SEE INSTRUCTIONS BEFORE FILLING OUT!

   <PAGE>
   Item 1.   Security and Issuer

             The title of the class of equity securities to which this
   statement relates is Common Stock, no par value per share (the "Common
   Stock").

             The name and address of the principal executive offices of the
   issuer of the Common Stock is Medwave, Inc. (the "Company"), 1410 Energy
   Park Drive, Suite 6, St. Paul, Minnesota  55108.

   Item 2.   Identity and Background

             The following information is provided for each person:

             (a)  Name.  William D. Corneliuson.

             (b)  Address.  777 East Wisconsin Avenue, Suite 3020,
        Milwaukee, Wisconsin  53202.

             (c)  Principal Occupation and Employment.  William D.
        Corneliuson is President and Treasurer of B.C. Holdings, Inc.,
        an investment advisory and consulting firm.

             (d)  Criminal Proceedings.  None.

             (e)  Civil Proceedings.  None.

             (f)  Citizenship.  United States.

   Item 3.   Source and Amount of Funds or other consideration

             William D. Corneliuson acquired all shares reported hereby with
   approximately $1,979,425 of his personal funds.

   Item 4.   Purpose of Transaction

             All of the reported shares were acquired for investment
   purposes.

             The reporting person has no plans or proposals which relate to
   or would result in:

             (a)  The acquisition by any person of additional securities
        of the Company, or the disposition of securities of the Company;

             (b)  An extraordinary corporate transaction, such as a
        merger, organization or liquidation, involving the Company or
        any of its subsidiaries;

             (c)  A sale or transfer of a material amount of assets of
        the Company or any of its subsidiaries;

             (d)  Any change in the present board of directors or
        management of the Company, including any plans or proposals to
        change the number or term of directors or to fill any existing
        vacancies on the board;

             (e)  Any material change in the present capitalization or
        dividend policy of the Company;

             (f)  Any other material change in the Company's business or
        corporate structure including but not limited to, if the Company
        is a registered closed-end investment company, any plans or
        proposals to make any changes in its investment policy for which
        a vote is required by section 13 of the Investment Company Act
        of 1940;

             (g)  Changes in the Company's charter, bylaws or
        instruments corresponding thereto or other actions which may
        impede the acquisition of control of the Company by any person;

             (h)  Causing a class of securities of the Company to be
        delisted from a national securities exchange or to cease to be
        authorized to be quoted in an inter-dealer quotation system of a
        registered national securities association;

             (i)  A class of equity securities of the Company becoming
        eligible for termination of registration pursuant to
        Section 12(g)(4) of the Act; or

             (j)  Any action similar to any of those enumerated above.

   Item 5.   Interest in Securities of the Issuer

             (a)  Number of Shares/Percentage of Class Beneficially Owned. 
   William D. Corneliuson beneficially owns a total of 240,000 shares of the
   Company's Common Stock representing approximately 5.1% of the outstanding
   shares of Common Stock based on 4,690,560 shares of Common Stock
   outstanding as of February 29, 1996 as indicated by the Company's
   Form 10-QSB for the quarter ended January 31, 1996.

             (b)  Nature of Ownership.  Mr. Corneliuson has sole power to
   vote and direct the disposition of all of the reported shares.

             (c)  Recent Transactions.  On May 23, 1996, William D.
   Corneliuson purchased 10,000 shares of Common Stock at $10.625 per share
   through the NASDAQ small cap market and 230,000 shares of Common Stock at
   $8.56 per share in a private transaction.

             (d)  Rights to Dividends or Proceeds.  None.

             (e)  Not applicable.

   Item 6.   Contracts, Arrangements, Understandings or Relationships with
   Respect to Securities of Issuer

             None.

   Item 7.   Materials to be Filed as Exhibits

             None.

   <PAGE>
                                    SIGNATURE

             After reasonable inquiry and to the best of my knowledge and
   belief, I certify that the information set forth in this statement is
   true, complete and correct.



        May 29, 1996                  /s/ William D. Corneliuson
           Date                       Signature



                                      William D. Corneliuson           
                                      Name/Title
    


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission